Results 241 to 250 of about 47,892 (267)
Some of the next articles are maybe not open access.
Disability and Rehabilitation, 2016
Purpose: The aim of the study was to compare the efficacy of Nordic pole walking (NPW) training with traditional treadmill training (TT) on a claudication (CD) and maximum walking distance (MWD) in patients with peripheral arterial disease (PAD). Method:
K. Bulińska +12 more
semanticscholar +1 more source
Purpose: The aim of the study was to compare the efficacy of Nordic pole walking (NPW) training with traditional treadmill training (TT) on a claudication (CD) and maximum walking distance (MWD) in patients with peripheral arterial disease (PAD). Method:
K. Bulińska +12 more
semanticscholar +1 more source
British Journal of Surgery, 2016
Current guidelines recommend supervised exercise therapy (SET) as the preferred initial treatment for patients with intermittent claudication. The availability of SET programmes is, however, limited and such programmes are often not reimbursed.
M. M. van den Houten +6 more
semanticscholar +1 more source
Current guidelines recommend supervised exercise therapy (SET) as the preferred initial treatment for patients with intermittent claudication. The availability of SET programmes is, however, limited and such programmes are often not reimbursed.
M. M. van den Houten +6 more
semanticscholar +1 more source
Angiology, 2015
We evaluated whether altered reporting of ischemic symptoms occurs in diabetic patients with peripheral arterial disease (PAD) and stable claudication.
F. Manfredini +7 more
semanticscholar +1 more source
We evaluated whether altered reporting of ischemic symptoms occurs in diabetic patients with peripheral arterial disease (PAD) and stable claudication.
F. Manfredini +7 more
semanticscholar +1 more source
Prostanoids for intermittent claudication
Cochrane Database of Systematic Reviews, 2013Peripheral arterial disease (PAD) is a common cause of morbidity in the general population. While numerous studies have established the efficacy of prostanoids in PAD stages III and IV, the question of the role of prostanoids as an alternative or additive treatment in patients suffering from intermittent claudication (PAD II) has not yet been clearly ...
Alina Andras, Lindsay Robertson
openaire +3 more sources
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication.
Cochrane Database of Systematic Reviews, 2013BACKGROUND Although supervised exercise therapy is considered to be of significant benefit for people with leg pain (peripheral arterial disease (PAD)), implementing supervised exercise programs (SETs) in daily practice has limitations. This is an update
H. Fokkenrood +5 more
semanticscholar +1 more source
Medical treatment of peripheral arterial disease and claudication.
New England Journal of Medicine, 2001ERIPHERAL arterial disease, which is caused by atherosclerotic occlusion of the arteries to the legs, is an important manifestation of systemic atherosclerosis.
W. Hiatt
semanticscholar +1 more source
Pharmacotherapy of intermittent claudication
Expert Opinion on Pharmacotherapy, 2001Intermittent claudication (IC) is leg muscle pain, cramping and fatigue brought on by exercise and is the primary symptom of peripheral arterial disease. The goals of pharmacotherapy for IC are to increase the walking capacity/quality of life and to decrease rates of amputation.
openaire +4 more sources
Overuse of early peripheral vascular interventions for claudication.
Journal of Vascular Surgery, 2020C. Hicks +5 more
semanticscholar +1 more source
Pentoxifylline for intermittent claudication
2005Intermittent claudication (IC) is a symptom of peripheral arterial occlusive disease (PAD). It is associated with high morbidity and mortality. Pentoxifylline is one of many drugs used to treat IC. Pentoxifylline decreases blood viscosity, improves erythrocyte flexibility, and increases microcirculatory flow and tissue oxygen concentration.Many studies
Kareem, Salhiyyah +4 more
openaire +2 more sources